Search
for
Sort by
Research 30 of 937
- Understanding Eyebrow and Eyelash Involvement in Patients with Alopecia Areata and Responsiveness to Treatment with Baricitinib.
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast
- Race and Ethnicity Sub-Groups of Alopecia Areata Patients have Differing Clinical Characteristics: TARGET-DERM AA
- Depression among Alopecia Areata Patients: Prevalence and associated factors in a Tunisian sample
- Frontalna fibrozirajuća alopecija
- Frontal fibrosing alopecia: a disease that remains enigmatic
- BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience
- Alopecia areata: Clinical presentation, diagnosis, and unusual cases
- Frontal fibrosing alopecia: A multicenter review of 355 patients
- Frontal fibrosing alopecia: A multicenter review of 355 patients
- Patient-Reported Psychosocial Burdens and Quality of Life and Work Productivity Impacts Among Patients with Clinically Distinct Alopecia Areata Severity Profiles
- Baricitinib Provides Holistic Improvement in Scalp, Eyebrow and Eyelash Regrowth in Adolescents With Severe Alopecia Areata
- 63532 Impact of Eyebrow and Eyelash Hair Loss on Health-Related Quality of Life Among Patients with Alopecia Areata: Results From a Real-World Survey in 5 European Countries
- Most men choose eyebrows versus scalp hair: Response to Mostaghimi et al., “Evaluation of eyebrow and eyelash regrowth and patient satisfaction in the phase 3 THRIVE-AA2 trial of deuruxolitinib in adult patients with alopecia areata”
- Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata
- Hypertrichosis Lanuginosa Acquisita: When Hair Unravels the Unseen
- Onychomadesis associated with childhood hand-foot-mouth disease
- Real‐World Outcomes and Safety of JAK Inhibitors in Paediatric Alopecia Areata: A Retrospective Multicentre Study
- Demographics and Disease Characteristics of Patients with Alopecia Areata with Comorbid Atopic Dermatitis, Vitiligo or Anxiety/Depression: TARGET-DERM AA
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Pili Annulati: A case series and proposal for classification
- Frontal Fibrosing Alopecia: A Comprehensive Review with Recent Updates
- Frontal fibrosing alopecia and lichen planus pigmentosus
- Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata
- Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Topical tofacitinib for the treatment of alopecia areata affecting facial hair
- Development and validation of the Brigham Eyelash Tool for Alopecia (BELA): A measure of eyelash alopecia areata
- 26143 Time to scalp hair, eyebrow, and eyelash improvement in patients with alopecia areata treated with baricitinib in the phase 2 portion of the phase 2/3 BRAVE-AA1 study